+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

Meningitis Diagnostic Testing Market Size, Share & Trends Analysis Report By Test Type (Latex Agglutination Tests, Lateral Flow Assay, PCR Assay, ELISA Tests, Culture Test), By End-user, By Region, And Segment Forecasts, 2023 - 2030

  • PDF Icon

    Report

  • 150 Pages
  • November 2022
  • Region: Global
  • Grand View Research
  • ID: 5702114
Description Jump to:
The global meningitis diagnostic testing market size is expected to reach USD 154.06 million by 2030, registering a CAGR of 3.68% over the forecast period. The growth of the market is accredited to the rising awareness among the people about early disease diagnosis and increasing demand for rapid diagnosis coupled with the high accuracy of the test. Moreover, the increasing government support to reduce the burden of disease and the rising number of diagnostic centers are other factors fueling market demand.

The increasing prevalence of infectious diseases, and HIV is increasing the risk of developing meningitis, which is increasing the demand for meningitis diagnostic tests, worldwide. For instance, according to the WHO, over 38.4 million people were living with HIV worldwide in 2021. In addition, according to CDC in 2020, around 30,635 people received HIV diagnoses in the U.S. High number of HIV infections may increase the testing rate for meningitis. Moreover, EV meningitis is estimated to result in around 30,000-50,000 hospitalizations every year in the U.S.

Thus, such a high incidence of target diseases is pushing manufacturers to develop precise diagnostic solutions. For instance, Cepheid offered Xpert EV, a fast molecular in vitro diagnostic EV test, which provides results in 2.5 hours with optimum sensitivity and specificity. Similarly, M-DiaMult of Diagenode Diagnostics is a type of PCR- CE-IVD kit that detects many bacterial infections including Neisseria meningitidis.

Meningitis infection has emerged as a global issue owing to its long-term consequences and high mortality rate. The government is offering active support to provide sophisticated diagnostic tests and treatment regimens to eradicate the disease. For instance, the Meningitis Research Foundation and the CDC offer referral diagnoses for different infectious diseases such as tuberculosis, malaria, and meningitis among others that are not available in hospitals. Thus, such government initiatives to promote the diagnosis of various infectious diseases are likely to offer lucrative growth opportunities for the market.

Furthermore, the surge in the healthcare sector developments and growing technological advancements in diagnostic tests are likely to offer robust growth opportunities for the market. For instance, in July 2022, Abacus Diagnostica, a leader in molecular diagnostic testing, launched a novel rapid PCR test in Europe markets for the quick identification of viruses causing encephalitis and meningitis. This newly launched test allows healthcare professionals to identify the most common virus those causes meningitis in a span of 70 minutes. The introduction of rapid tests with high accuracy is anticipated to propel the market growth in the coming years.

Meningitis Diagnostic Testing Market Report Highlights

  • PCR assay segment held the largest market share in 2022 owing to a high preference for PCR tests and higher sensitivity and lower turnaround times of the test
  • Lateral flow assay is expected to be the fastest segment during the coming years due to the increasing adoption of rapid tests at different healthcare facilities
  • Hospitals segment was the leading revenue contributor during the base year and its high revenue is attributed to increasing access to novel diagnostic technologies and improved healthcare coverage
  • The diagnostic centers segment is anticipated to exhibit the fastest growth rate owing to the surge in the burden of infectious diseases and the increasing adoption of technologically advanced products
  • Asia Pacific is expected to exhibit the fastest growth over the forecast period due to rising investments in the region and ongoing trials in the region


This product will be delivered within 1-3 business days.

Table of Contents

Chapter 1 Methodology and Scope
1.1 Market Segmentation and Scope
1.1.1 Segment scope
1.1.2 Regional scope
1.1.3 Estimates and forecast timeline
1.2 Research Methodology
1.3 Information Procurement
1.3.1 Purchased database:
1.3.2 internal database
1.3.3 Secondary sources
1.3.4 Primary research
1.3.5 Details of primary research
1.4 Information or Data Analysis
1.4.1 Data analysis models
1.5 Market Formulation & Validation
1.6 Model Details
1.6.1 Commodity Flow Analysis
1.6.1.1 Approach: Commodity Flow Approach
1.7 Research Assumptions
1.8 List of Secondary Sources
1.9 List of Abbreviations
1.10 Objectives
1.10.1 Objective 1
1.10.2 Objective 2
1.10.3 Objective 3
1.10.4 Objective 4
Chapter 2 Executive Summary
2.1 Market Outlook
2.2 Competitive Insights
Chapter 3 Meningitis Diagnostic Testing Market Variables, Trends, & Scope
3.1 Market Lineage Outlook
3.1.1 Parent market
3.2 Market Dynamics
3.2.1 Market drivers analysis
3.2.1.1 Increasing prevalence of meningitis
3.2.1.2 Rise in demand for rapid diagnosis by using innovative technologies
3.2.1.3 Active government support to control meningitis disease outbreak
3.2.2 Market restraint analysis
3.2.2.1 Stringent regulatory framework
3.3 Penetration & Growth Prospect Mapping
3.4 Meningitis Diagnostic Testing: Market Analysis Tools
3.4.1 Industry analysis - Porter’s
3.4.2 PESTLE analysis
3.5 Regulatory Framework
3.6 Pricing Analysis
Chapter 4 Meningitis Diagnostic Testing Market Segment Analysis, By Test Type, 2018 - 2030 (USD Million)
4.1 Definition and Scope
4.2 Test Type Market Share Analysis, 2022 & 2030
4.3 Segment Dashboard
4.4 Global Meningitis Diagnostic Testing Market, by Test Type, 2018 to 2030
4.5 Market Size & Forecasts and Trend Analyses, 2018 to 2030
4.5.1 Latex Agglutination
4.5.1.1 Latex agglutination market, 2018 - 2030 (USD million)
4.5.2 Lateral Flow Assay
4.5.2.1 Lateral flow assay market, 2018 - 2030 (USD million)
4.5.3 PCR Assay
4.5.3.1 PCR assay market, 2018 - 2030 (USD million)
4.5.4 ELISA Tests
4.5.4.1 ELISA tests market, 2018 - 2030 (USD million)
4.5.5 Culture Test
4.5.5.1 Culture test market, 2018 - 2030 (USD million)
4.5.6 Others
4.5.6.1 Others market, 2018 - 2030 (USD million)
Chapter 5 Meningitis Diagnostic Testing Market Segment Analysis, By End-User 2018 - 2030 (USD Million)
5.1 Definition and Scope
5.2 End-User Market Share Analysis, 2022 & 2030
5.3 Segment Dashboard
5.4 Global Meningitis Diagnostic Testing Market, by End-User, 2018 to 2030
5.5 Market Size & Forecasts and Trend Analyses, 2018 to 2030
5.5.1 Hospitals
5.5.1.1 Hospitals market, 2018 - 2030 (USD million)
5.5.2 Diagnostic Centers
5.5.2.1 Diagnostic centers market, 2018 - 2030 (USD million)
5.5.3 Others
5.5.3.1 Others market, 2018 - 2030 (USD million)
Chapter 6 Meningitis Diagnostic Testing Market Segment Analysis, By Region, 2018 - 2030 (USD Million)
6.1 Definition & Scope
6.2 Regional Market Share Analysis, 2022 & 2030
6.3 Regional Market Dashboard
6.4 Regional Market Snapshot
6.5 SWOT Analysis
6.5.1 North America
6.5.2 Europe
6.5.3 Asia Pacific
6.5.4 Latin America
6.5.5 Middle East and Africa
6.6 Market Size, & Forecasts, Revenue and Trend Analysis, 2018 to 2030
6.6.1 North America
6.6.1.1 North America market estimates and forecast, 2018 - 2030 (USD million)
6.6.1.2 U.S.
6.6.1.2.1 U.S. meningitis diagnostic testing market, 2018 - 2030 (USD million)
6.6.1.3 Canada
6.6.1.3.1 Canada meningitis diagnostic testing market, 2018 - 2030 (USD million)
6.6.2 Europe
6.6.2.1 Europe meningitis diagnostic testing market, 2018 - 2030 (USD million)
6.6.2.2 U.K.
6.6.2.2.1 U.K. meningitis diagnostic testing market, 2018 - 2030 (USD million)
6.6.2.3 Germany
6.6.2.3.1 Germany meningitis diagnostic testing market, 2018 - 2030 (USD million)
6.6.2.4 Spain
6.6.2.4.1 Spain meningitis diagnostic testing market, 2018 - 2030 (USD million)
6.6.2.5 France
6.6.2.5.1 France meningitis diagnostic testing market, 2018 - 2030 (USD million)
6.6.2.6 Italy
6.6.2.6.1 Italy meningitis diagnostic testing market, 2018 - 2030 (USD million)
6.6.2.7 Denmark
6.6.2.7.1 Denmark meningitis diagnostic testing market, 2018 - 2030 (USD million)
6.6.2.8 Sweden
6.6.2.8.1 Sweden meningitis diagnostic testing market, 2018 - 2030 (USD million)
6.6.2.9 Norway
6.6.2.9.1 Norway meningitis diagnostic testing market, 2018 - 2030 (USD million)
6.6.3 Asia Pacific
6.6.3.1 Asia Pacific meningitis diagnostic testing market, 2018 - 2030 (USD million)
6.6.3.2 Japan
6.6.3.2.1 Japan meningitis diagnostic testing market, 2018 - 2030 (USD million)
6.6.3.3 China
6.6.3.3.1 China meningitis diagnostic testing market, 2018 - 2030 (USD million)
6.6.3.4 India
6.6.3.4.1 India meningitis diagnostic testing market, 2018 - 2030 (USD million)
6.6.3.5 South Korea
6.6.3.5.1 South Korea meningitis diagnostic testing market, 2018 - 2030 (USD million)
6.6.3.6 Australia
6.6.3.6.1 Australia meningitis diagnostic testing market, 2018 - 2030 (USD million)
6.6.3.7 Thailand
6.6.3.7.1 Thailand meningitis diagnostic testing market, 2018 - 2030 (USD million)
6.6.4 Latin America
6.6.4.1 Latin America meningitis diagnostic testing market, 2018 - 2030 (USD million)
6.6.4.2 Brazil
6.6.4.2.1 Brazil meningitis diagnostic testing market, 2018 - 2030 (USD million)
6.6.4.3 Mexico
6.6.4.3.1 Mexico meningitis diagnostic testing market, 2018 - 2030 (USD million)
6.6.4.4 Argentina
6.6.4.4.1 Argentina meningitis diagnostic testing market, 2018 - 2030 (USD million)
6.6.5 MEA
6.6.5.1 MEA meningitis diagnostic testing market, 2018 - 2030 (USD million)
6.6.5.2 South Africa
6.6.5.2.1 South Africa meningitis diagnostic testing market, 2018 - 2030 (USD million)
6.6.5.3 Saudi Arabia
6.6.5.3.1 Saudi Arabia meningitis diagnostic testing market, 2018 - 2030 (USD million)
6.6.5.4 UAE
6.6.5.4.1 UAE meningitis diagnostic testing market, 2018 - 2030 (USD million)
6.6.5.5 Kuwait
6.6.5.5.1 Kuwait meningitis diagnostic testing market, 2018 - 2030 (USD million)
Chapter 7 Meningitis Diagnostic Testing Market - Competitive Analysis
7.1 Recent Developments & Impact Analysis, by Key Market Participants
7.1.1 Ansoff matrix
7.1.2 Heat map analysis
7.1.3 Major Deals and Strategic Alliances Analysis
7.1.3.1 Joint Ventures
7.1.3.2 Licensing Agreements
7.1.3.3 Product Launches
7.1.3.1 Conferences and Campaigns
7.2 Company Categorization
7.2.1 Innovators
7.2.2 Market Leaders
7.3 Vendor Landscape
7.3.1 List of key distributors and channel partners
7.3.2 Key customers
7.4 Public Companies
7.4.1 Competitive Dashboard Analysis
7.4.1.1 Market Differentiators
7.5 Private Companies
7.5.1 List of key emerging companies
7.6 Company Profiles
7.6.1 Thermo Fisher Scientific, Inc.
7.6.1.1 Company overview
7.6.1.2 Financial performance
7.6.1.3 Product benchmarking
7.6.1.4 Strategic initiatives
7.6.2 Bio-Rad Laboratories, Inc.
7.6.2.1 Company overview
7.6.2.2 Financial performance
7.6.2.3 Product benchmarking
7.6.2.4 Strategic initiatives
7.6.3 Abbott
7.6.3.1 Company overview
7.6.3.2 Financial performance
7.6.3.3 Product benchmarking
7.6.3.4 Strategic initiatives
7.6.4 ELITechGroup
7.6.4.1 Company overview
7.6.4.2 Financial performance
7.6.4.3 Product benchmarking
7.6.4.4 Strategic initiatives
7.6.5 Seegene Inc.
7.6.5.1 Company overview
7.6.5.2 Financial performance
7.6.5.3 Product benchmarking
7.6.5.4 Strategic initiatives
7.6.6 Luminex Corporation
7.6.6.1 Company overview
7.6.6.2 Financial performance
7.6.6.3 Product benchmarking
7.6.6.4 Strategic initiatives
7.6.7 CERTEST BIOTEC
7.6.7.1 Company overview
7.6.7.2 Financial performance
7.6.7.3 Product benchmarking
7.6.7.4 Strategic initiatives
7.6.8 IMMY
7.6.8.1 Company overview
7.6.8.2 Financial performance
7.6.8.3 Product benchmarking
7.6.8.4 Strategic initiatives
7.6.9 Uniogen Oy
7.6.9.1 Company overview
7.6.9.2 Financial performance
7.6.9.3 Product benchmarking
7.6.9.4 Strategic initiatives
List of Tables
Table 1 List of Secondary Sources
Table 2 List of Abbreviations
Table 3 Leading Market Players Anticipated to Witness Highest Growth
Table 4 Global Meningitis Diagnostic Testing Market, By Region, 2018 - 2030 (USD Million)
Table 5 Global Meningitis Diagnostic Testing Market, By Test Type, 2018 - 2030 (USD Million)
Table 6 Global Meningitis Diagnostic Testing Market, By End-User, 2018 - 2030 (USD Million)
Table 7 North America Meningitis Diagnostic Testing Market, By Country, 2018 - 2030 (USD Million)
Table 8 North America Meningitis Diagnostic Testing Market, By Test Type, 2018 - 2030 (USD Million)
Table 9 North America Meningitis Diagnostic Testing Market, By End-User, 2018 - 2030 (USD Million)
Table 10 U.S. Meningitis Diagnostic Testing Market, By Test Type, 2018 - 2030 (USD Million)
Table 11 U.S. Meningitis Diagnostic Testing Market, By End-User, 2018 - 2030 (USD Million)
Table 12 Canada Meningitis Diagnostic Testing Market, By Test Type, 2018 - 2030 (USD Million)
Table 13 Canada Meningitis Diagnostic Testing Market, By End-User, 2018 - 2030 (USD Million)
Table 14 Europe Meningitis Diagnostic Testing Market, By Country, 2018 - 2030 (USD Million)
Table 15 Europe Meningitis Diagnostic Testing Market, By Test Type, 2018 - 2030 (USD Million)
Table 16 Europe Meningitis Diagnostic Testing Market, By End-User, 2018 - 2030 (USD Million)
Table 17 U.K. Meningitis Diagnostic Testing Market, By Test Type, 2018 - 2030 (USD Million)
Table 18 U.K. Meningitis Diagnostic Testing Market, By End-User, 2018 - 2030 (USD Million)
Table 19 Germany Meningitis Diagnostic Testing Market, By Test Type, 2018 - 2030 (USD Million)
Table 20 Germany Meningitis Diagnostic Testing Market, By End-User, 2018 - 2030 (USD Million)
Table 21 France Meningitis Diagnostic Testing Market, By Test Type, 2018 - 2030 (USD Million)
Table 22 France Meningitis Diagnostic Testing Market, By End-User, 2018 - 2030 (USD Million)
Table 23 Spain Meningitis Diagnostic Testing Market, By Test Type, 2018 - 2030 (USD Million)
Table 24 Spain Meningitis Diagnostic Testing Market, By End-User, 2018 - 2030 (USD Million)
Table 25 Italy Meningitis Diagnostic Testing Market, By Test Type, 2018 - 2030 (USD Million)
Table 26 Italy Meningitis Diagnostic Testing Market, By End-User, 2018 - 2030 (USD Million)
Table 27 Denmark Meningitis Diagnostic Testing Market, By Test Type, 2018 - 2030 (USD Million)
Table 28 Denmark Meningitis Diagnostic Testing Market, By End-User, 2018 - 2030 (USD Million)
Table 29 Norway Meningitis Diagnostic Testing Market, By Test Type, 2018 - 2030 (USD Million)
Table 30 Norway Meningitis Diagnostic Testing Market, By End-User, 2018 - 2030 (USD Million)
Table 31 Sweden Meningitis Diagnostic Testing Market, By Test Type, 2018 - 2030 (USD Million)
Table 32 Sweden Meningitis Diagnostic Testing Market, By End-User, 2018 - 2030 (USD Million)
Table 33 Asia Pacific Meningitis Diagnostic Testing Market, By Country, 2018 - 2030 (USD Million)
Table 34 Asia Pacific Meningitis Diagnostic Testing Market, By Test Type, 2018 - 2030 (USD Million)
Table 35 Asia Pacific Meningitis Diagnostic Testing Market, By End-User, 2018 - 2030 (USD Million)
Table 36 Japan Meningitis Diagnostic Testing Market, By Test Type, 2018 - 2030 (USD Million)
Table 37 Japan Meningitis Diagnostic Testing Market, By End-User, 2018 - 2030 (USD Million)
Table 38 China Meningitis Diagnostic Testing Market, By Test Type, 2018 - 2030 (USD Million)
Table 39 China Meningitis Diagnostic Testing Market, By End-User, 2018 - 2030 (USD Million)
Table 40 India Meningitis Diagnostic Testing Market, By Test Type, 2018 - 2030 (USD Million)
Table 41 India Meningitis Diagnostic Testing Market, By End-User, 2018 - 2030 (USD Million)
Table 42 Australia Meningitis Diagnostic Testing Market, By Test Type, 2018 - 2030 (USD Million)
Table 43 Australia Meningitis Diagnostic Testing Market, By End-User, 2018 - 2030 (USD Million)
Table 44 South Korea Meningitis Diagnostic Testing Market, By Test Type, 2018 - 2030 (USD Million)
Table 45 South Korea Meningitis Diagnostic Testing Market, By End-User, 2018 - 2030 (USD Million)
Table 46 Thailand Meningitis Diagnostic Testing Market, By Test Type, 2018 - 2030 (USD Million)
Table 47 Thailand Meningitis Diagnostic Testing Market, By End-User, 2018 - 2030 (USD Million)
Table 48 Latin America Meningitis Diagnostic Testing Market, By Country, 2018 - 2030 (USD Million)
Table 49 Latin America Meningitis Diagnostic Testing Market, By Test Type, 2018 - 2030 (USD Million)
Table 50 Latin America Meningitis Diagnostic Testing Market, By End-User, 2018 - 2030 (USD Million)
Table 51 Brazil Meningitis Diagnostic Testing Market, By Test Type, 2018 - 2030 (USD Million)
Table 52 Brazil Meningitis Diagnostic Testing Market, By End-User, 2018 - 2030 (USD Million)
Table 53 Argentina Meningitis Diagnostic Testing Market, By Test Type, 2018 - 2030 (USD Million)
Table 54 Argentina Meningitis Diagnostic Testing Market, By End-User, 2018 - 2030 (USD Million)
Table 55 Mexico Meningitis Diagnostic Testing Market, By Test Type, 2018 - 2030 (USD Million)
Table 56 Mexico Meningitis Diagnostic Testing Market, By End-User, 2018 - 2030 (USD Million)
Table 57 Middle East and Africa Meningitis Diagnostic Testing Market, By Country, 2018 - 2030 (USD Million)
Table 58 Middle East and Africa Meningitis Diagnostic Testing Market, By Test Type, 2018 - 2030 (USD Million)
Table 59 Middle East and Africa Meningitis Diagnostic Testing Market, By End-User, 2018 - 2030 (USD Million)
Table 60 South Africa Meningitis Diagnostic Testing Market, By Test Type, 2018 - 2030 (USD Million)
Table 61 South Africa Meningitis Diagnostic Testing Market, By End-User, 2018 - 2030 (USD Million)
Table 62 Saudi Arabia Meningitis Diagnostic Testing Market, By Test Type, 2018 - 2030 (USD Million)
Table 63 Saudi Arabia Meningitis Diagnostic Testing Market, By End-User, 2018 - 2030 (USD Million)
Table 64 UAE Meningitis Diagnostic Testing Market, By Test Type, 2018 - 2030 (USD Million)
Table 65 UAE Meningitis Diagnostic Testing Market, By End-User, 2018 - 2030 (USD Million)
Table 66 Kuwait Meningitis Diagnostic Testing Market, By Test Type, 2018 - 2030 (USD Million)
Table 67 Kuwait Meningitis Diagnostic Testing Market, By End-User, 2018 - 2030 (USD Million)
List of Figures
Fig. 1 Meningitis diagnostic testing market segmentation
Fig. 2 Market research process
Fig. 3 Information procurement
Fig. 4 Primary research pattern
Fig. 5 Market research approaches
Fig. 6 Value-chain-based sizing & forecasting
Fig. 7 QFD modeling for market share assessment
Fig. 8 Market formulation & validation
Fig. 9 Market outlook (2022)
Fig. 10 Strategy framework
Fig. 11 Market driver relevance analysis (Current & future impact)
Fig. 12 Market restraint relevance analysis (Current & future impact)
Fig. 13 Penetration & growth prospect mapping
Fig. 14 Porter’s five forces analysis
Fig. 15 PESTLE analysis
Fig. 16 Meningitis Diagnostic Testing market: Test type movement analysis
Fig. 17 Meningitis Diagnostic Testing market: Test type segment dashboard
Fig. 18 Meningitis Diagnostic Testing market Test type outlook: Key takeaways
Fig. 19 Latex agglutination market, 2018 - 2030 (USD million)
Fig. 20 Lateral flow assay market, 2018 - 2030 (USD million)
Fig. 21 PCR assay market, 2018 - 2030 (USD million)
Fig. 22 ELISA tests market, 2018 - 2030 (USD million)
Fig. 23 Culture test market, 2018 - 2030 (USD million)
Fig. 24 Others market, 2018 - 2030 (USD million)
Fig. 25 Meningitis Diagnostic Testing market: End-user analysis
Fig. 26 Meningitis Diagnostic Testing market: End-user segment dashboard
Fig. 27 Meningitis Diagnostic Testing market End-user outlook: Key takeaways
Fig. 28 Hospitals market, 2018 - 2030 (USD million)
Fig. 29 Diagnostic centers market, 2018 - 2030 (USD million)
Fig. 30 Others market, 2018 - 2030 (USD million)
Fig. 31 Regional outlook, 2022 & 2030
Fig. 32 Regional market dashboard
Fig. 33 Regional market place: Key takeaways
Fig. 34 North America, SWOT
Fig. 35 Europe, SWOT
Fig. 36 Asia Pacific, SWOT
Fig. 37 Latin America, SWOT
Fig. 38 Middle East and Africa, SWOT
Fig. 39 North America
Fig. 40 North America meningitis diagnostic testing market, 2018 - 2030 (USD million)
Fig. 41 U.S.
Fig. 42 U.S. meningitis diagnostic testing market, 2018 - 2030 (USD million)
Fig. 43 Canada
Fig. 44 Canada meningitis diagnostic testing market, 2018 - 2030 (USD million)
Fig. 45 Europe
Fig. 46 Europe meningitis diagnostic testing market, 2018 - 2030 (USD million)
Fig. 47 U.K.
Fig. 48 U.K. meningitis diagnostic testing market, 2018 - 2030 (USD million)
Fig. 49 Germany
Fig. 50 Germany meningitis diagnostic testing market, 2018 - 2030 (USD million)
Fig. 51 Spain
Fig. 52 Spain meningitis diagnostic testing market, 2018 - 2030 (USD million)
Fig. 53 France
Fig. 54 France meningitis diagnostic testing market, 2018 - 2030 (USD million)
Fig. 55 Italy
Fig. 56 Italy meningitis diagnostic testing market, 2018 - 2030 (USD million)
Fig. 57 Denmark
Fig. 58 Denmark meningitis diagnostic testing market, 2018 - 2030 (USD million)
Fig. 59 Sweden
Fig. 60 Sweden meningitis diagnostic testing market, 2018 - 2030 (USD million)
Fig. 61 Norway
Fig. 62 Norway meningitis diagnostic testing market, 2018 - 2030 (USD million)
Fig. 63 Asia Pacific
Fig. 64 Asia Pacific meningitis diagnostic testing market, 2018 - 2030 (USD million)
Fig. 65 Japan
Fig. 66 Japan meningitis diagnostic testing market, 2018 - 2030 (USD million)
Fig. 67 China
Fig. 68 China meningitis diagnostic testing market, 2018 - 2030 (USD million)
Fig. 69 India
Fig. 70 India meningitis diagnostic testing market, 2018 - 2030 (USD million)
Fig. 71 South Korea
Fig. 72 South Korea meningitis diagnostic testing market, 2018 - 2030 (USD million)
Fig. 73 Australia
Fig. 74 Australia meningitis diagnostic testing market, 2018 - 2030 (USD million)
Fig. 75 Thailand
Fig. 76 Thailand meningitis diagnostic testing market, 2018 - 2030 (USD million)
Fig. 77 Latin America
Fig. 78 Latin America meningitis diagnostic testing market, 2018 - 2030 (USD million)
Fig. 79 Brazil
Fig. 80 Brazil meningitis diagnostic testing market, 2018 - 2030 (USD million)
Fig. 81 Mexico
Fig. 82 Mexico meningitis diagnostic testing market, 2018 - 2030 (USD million)
Fig. 83 Argentina
Fig. 84 Argentina meningitis diagnostic testing market, 2018 - 2030 (USD million)
Fig. 85 Middle East and Africa
Fig. 86 MEA meningitis diagnostic testing market, 2018 - 2030 (USD million)
Fig. 87 South Africa
Fig. 88 South Africa meningitis diagnostic testing market, 2018 - 2030 (USD Million)
Fig. 89 Saudi Arabia
Fig. 90 Saudi Arabia meningitis diagnostic testing market, 2018 - 2030 (USD million)
Fig. 91 UAE
Fig. 92 UAE meningitis diagnostic testing market, 2018 - 2030 (USD million)
Fig. 93 Kuwait
Fig. 94 Kuwait meningitis diagnostic testing market, 2018 - 2030 (USD million)
Fig. 95 Ansoff Matrix
Fig. 96 Heat map analysis
Fig. 97 Market differentiators

Companies Mentioned

  • Thermo Fisher Scientific, Inc.
  • Bio-Rad Laboratories, Inc.
  • Abbott
  • Elitechgroup
  • Seegene Inc.
  • Luminex Corporation
  • Certest Biotec
  • Immy
  • Uniogen Oy

Methodology

Loading
LOADING...

Table Information

Report AttributeDetails
No. of Pages150
PublishedNovember 2022
Forecast Period2022 - 2030
Estimated Market Value ( USD ) in 2022 $ 120 Million
Forecasted Market Value ( USD ) by 2030 $ 154.06 Million
Compound Annual Growth Rate3.6%
Regions CoveredGlobal
No. of Companies Mentioned9

Related Topics

Related Reports

Meningitis Diagnostic Testing - Global Strategic Business Report - Product Image

Meningitis Diagnostic Testing - Global Strategic Business Report

  • Report
  • 174 Pages
  • Global
From
Meningitis Diagnostic Testing - Market Share Analysis, Industry Trends & Statistics, Growth Forecasts 2021 - 2029 - Product Image

Meningitis Diagnostic Testing - Market Share Analysis, Industry Trends & Statistics, Growth Forecasts 2021 - 2029

  • Report
  • 120 Pages
  • Global
From
Meningitis Diagnostic Testing Global Market Insights 2024, Analysis and Forecast to 2029, by Manufacturers, Regions, Technology, Application - Product Image

Meningitis Diagnostic Testing Global Market Insights 2024, Analysis and Forecast to 2029, by Manufacturers, Regions, Technology, Application

  • Report
  • 92 Pages
  • Global
From
Meningitis Diagnosis and Treatment Global Market Insights 2023, Analysis and Forecast to 2028, by Manufacturers, Regions, Technology, Application, Product Type - Product Image

Meningitis Diagnosis and Treatment Global Market Insights 2023, Analysis and Forecast to 2028, by Manufacturers, Regions, Technology, Application, Product Type

  • Report
  • 85 Pages
  • Global
From
2023-2028 Global Virology, Bacteriology, Parasitology and Mycology Testing Market in the US, Europe and Japan - 2023 Supplier Shares by Test, 2023-2028 Centralized and POC Volume and Sales Forecasts - Product Image

2023-2028 Global Virology, Bacteriology, Parasitology and Mycology Testing Market in the US, Europe and Japan - 2023 Supplier Shares by Test, 2023-2028 Centralized and POC Volume and Sales Forecasts

  • Report
  • Europe, Global, Japan, ... Europe, Global, Japan, United States
From
Copyright © 2002-2024 Research and Markets. All Rights Reserved.